SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001723128-21-000020
Filing Date
2021-05-07
Accepted
2021-05-07 06:17:33
Documents
16
Period of Report
2021-05-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K amrx-20210507.htm   iXBRL 8-K 37375
2 EX-99.1 amrx-q12021ex991.htm EX-99.1 353174
8 amneal1.jpg GRAPHIC 2670
  Complete submission text file 0001723128-21-000020.txt   564502

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT amrx-20210507.xsd EX-101.SCH 2514
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT amrx-20210507_cal.xml EX-101.CAL 799
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT amrx-20210507_def.xml EX-101.DEF 1763
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT amrx-20210507_lab.xml EX-101.LAB 24275
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT amrx-20210507_pre.xml EX-101.PRE 12735
9 EXTRACTED XBRL INSTANCE DOCUMENT amrx-20210507_htm.xml XML 10780
Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Filer) CIK: 0001723128 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38485 | Film No.: 21900113
SIC: 2834 Pharmaceutical Preparations